(Q45861280)

17 December 2017

title

Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response (English)

1 reference

17 December 2017

1 reference

Tsunenori Kondo

1

1 reference

17 December 2017

Hayakazu Nakazawa

2

1 reference

17 December 2017

Fumio Ito

3

1 reference

17 December 2017

Yasunobu Hashimoto

4

1 reference

17 December 2017

Yukinari Osaka

5

1 reference

17 December 2017

Kazuya Futatsuyama

6

1 reference

17 December 2017

Hiroshi Toma

7

1 reference

17 December 2017

Kazunari Tanabe

8

1 reference

17 December 2017

publication date

1 August 2006

1 reference

17 December 2017

published in

Cancer Science

1 reference

17 December 2017

volume

97

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

780-786

1 reference

17 December 2017

The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

Human chemokines: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

Structure and expression of two highly related genes encoding SCM-1/human lymphotactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

A new class of membrane-bound chemokine with a CX3C motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

Chemokines: agents for the immunotherapy of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

Patterns of Human Tumor-Infiltrating Lymphocytes in 120 Human Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

An assessment of the immunological status of patients with renal cell carcinoma based on the relative abundance of T-helper 1- and -2 cytokine-producing CD4+ cells in peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00231.X

10.1111/J.1349-7006.2006.00231.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017